A systems immunology approach reveals divergent immune profiles of RSV and SARS-CoV-2 infections in infants
Authors:
- Asa ThibodeauATAsa Thibodeau
- Asuncion MejiasAMAsuncion Mejias
- Djamel Nehar-BelaidDNDjamel Nehar-Belaid
- Zhaohui XuZXZhaohui Xu
- Giray EryilmazGEGiray Eryilmaz
- Steven Z. JosefowiczSJSteven Z. Josefowicz
- Bart JonesBJBart Jones
- Marie WehenkelMWMarie Wehenkel
- Silke PaustSPSilke Paust
- Virginia PascualVPVirginia Pascual
- Jacques BanchereauJBJacques Banchereau
- 25 February 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (838) , eaea7097
Abstract
Respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in infants differ substantially in their clinical presentations and outcomes. RSV is the leading cause of severe lower respiratory tract infection in infants, whereas SARS-CoV-2 infections are typically milder and do not necessarily involve the lower respiratory tract. To uncover immune mechanisms associated with these differences, we analyzed blood samples from infants (median age, 2.3 months) infected with RSV ( n = 19) or SARS-CoV-2 ( n = 30), as well as healthy control infants ( n = 17), using cytokine profiling, single-cell transcriptomics, and epigenomics. Both viruses induced comparable interferon-stimulated gene signatures but displayed disease-specific signatures in the individual cell types analyzed. Specifically, RSV was associated with increased CD4 + terminal effector memory T cell and memory regulatory T cell frequencies in the peripheral blood. Infants with severe RSV had reduced natural killer cell frequencies in the blood, lower IFNG expression in CD56 dim natural killer cells, and diminished chromatin accessibility at T-BET and EOMES binding sites in CD56 dim and CD56 bright natural killer cells. In contrast, infants infected with SARS-CoV-2 showed heightened proinflammatory responses in the blood, including higher nuclear factor κB pathway activity and serum tumor necrosis factor concentrations. These results highlight the distinct nature of infant immune responses to RSV and SARS-CoV-2 infections, offering insights that may help explain differences in the clinic and guide therapies.Keywords
Funding Information
- National Institutes of Health (U01 AI131386)
- National Institutes of Health (U19 AI168632)
- National Institutes of Health (U01 AI165452)
This publication has 64 references indexed in Scilit:
- Type I IFN drives unconventional IL-1β secretion in lupus monocytesImmunity, 2024
- Long-term alterations in lung epithelial cells after EL-RSV infection exacerbate allergic responses through IL-1β-induced pathwaysMucosal Immunology, 2024
- Single‐cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infantsClinical and Translational Medicine, 2023
- Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birthCell, 2023
- Epigenetic memory of coronavirus infection in innate immune cells and their progenitorsCell, 2023
- Integrated analysis of multimodal single-cell dataCell, 2021
- Chromatin Potential Identified by Shared Single-Cell Profiling of RNA and ChromatinCell, 2020
- Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic DataCell Systems, 2019
- IFNG-AS1 Enhances Interferon Gamma Production in Human Natural Killer CellsiScience, 2019
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010